European Archives - Page 658 of 1062 - European Medical Journal

ESHRE 2019 – Interview – Prof Claire Roberts

An interview with Prof Claire Roberts, Lloyd Cox Professorial Research Fellow, University of Adelaide, at this year’s ESHRE congress in Vienna, Austria…

EMJ Interventional Cardiology 7 [Supplement 1] 2019

This review examines the evidence on long-term prognosis, state-of-the-art assessment and treatment strategies, and the overwhelming need for…

Microvascular Angina: Diagnosis, Assessment, and Treatment

This review examines the evidence on long-term prognosis, state-of-the-art assessment and treatment strategies, and the overwhelming need for standardisation of diagnostic pathways in this patient population.

Designing a new approach to UX

In an era when UX is becoming fundamental to businesses globally, the role of design teams in pharma companies is taking on a whole new meaning.

The developing world: an innovation hub

Many of the most transformative innovations are taking place in the developing world on an increasingly regular basis. This article explores this phenomenon in healthcare and the key lessons pharma can take when creating their own innovative products.

Comprehensive Genomic Profiling (CGP) Enabled by Next-Generation Sequencing Technology

CGP enabled by next-generation sequencing (NGS) technology allows all known biomarkers to be evaluated in a single test.

Creativity For Good | Creativity For Growth

Pharma is seeing a host of ground-breaking innovations, with companies developing new technologies that are changing patients’ lives and helping to develop a more patient-centric industry

Should pharma tune into the ‘earfluence’ of the podcast?

As podcasts become a popular medium for learning and knowledge sharing, should the pharmaceutical industry give them a go as a way to educate patients and healthcare professionals?

An interview with Sam Glassenberg from Level Ex

We recently met with Sam Glassenberg, Founder and CEO, Level Ex, at the 2019 Cannes Lions Festival of Creativity…

A Multi-Disciplinary Review of the Evidence Supporting Metastasis-Free Survival (MFS) and the Benefit of Delaying Metastasis in High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

This review aims to summarise the evidence supporting the use of MFS as a clinical endpoint and the benefit of delaying metastasis in men with high-risk…